查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428301

2024 年罕见疾病诊断全球市场报告

Rare Disease Diagnostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

罕见疾病诊断的市场规模预计在未来几年将显着成长。预计到 2028 年将以 9.3% 的复合年增长率 (CAGR) 增长至 499.4 亿美元。预测期内的预期增长可归因于罕见疾病盛行率的增加、政府措施的增加、医院和诊断实验室数量的增加、血液疾病的扩大以及医疗保健基础设施的增加。预测期内预计的主要趋势包括基因检测技术的进步、全基因测序和次世代定序（NGS）的引入、大规模投资以及研究倡议的策略合作。

由于罕见疾病发生率的增加，罕见疾病诊断市场有望成长。罕见疾病在人群中盛行率较低，需要专门诊断才能进行有效管理、确定潜在治疗方法并避免不必要的治疗。例如，国际骨质疏鬆基金会 (IOF) 2021 年 2 月的资料强调，全球有超过 3 亿人患有罕见疾病，影响全球人口的 3.5% 至 5.9%。此外，Health Match 于 2022 年 11 月报道，美国和欧洲约有 150 种罕见肾臟疾病，盛行率为每 10 万人 60 至 80 例。因此，罕见疾病发生率的上升将推动罕见疾病诊断市场的成长。

人口老化加剧是推动罕见疾病诊断市场扩张的另一个因素。随着人口老化，对罕见疾病诊断促进的早期检测和个人化治疗方法的需求日益增长。根据美国人口普查局2023年6月报告，2022年美国中位数年龄将上升至38.9岁，显示人口老化趋势持续。这种人口结构的变化透过改善老年人健康状况的整体管理，促进了罕见疾病诊断市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 市场促进因素/市场抑制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年市场规模与成长表现
  • 2023-2028、2033 年市场规模与成长预测

第六章市场区隔

  • 全球罕见疾病诊断市场，按测试类型细分、实际和预测，2018-2023、2023-2028、2033
  • 基因检测
  • 一般临床检查
  • 影像检查
  • 全球罕见疾病诊断市场，依技术、绩效及预测细分，2018-2023、2023-2028、2033
  • 毛细管序列
  • 全基因测序
  • 全EXOME定序
  • 微阵列
  • 全球罕见疾病诊断市场，依样本类型、绩效及预测细分，2018-2023、2023-2028、2033
  • DNA样本
  • 口腔拭子样本
  • 血
  • 唾液
  • 全球罕见疾病诊断市场，依疾病类型、绩效及预测细分，2018-2023、2023-2028、2033
  • 消化系统疾病
  • 内分泌/代谢紊乱
  • 血液/肿瘤疾病
  • 皮肤病
  • 心血管疾病
  • 神经系统疾病
  • 全球罕见疾病诊断市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院实验室
  • 诊断实验室
  • 基因检测实验室
  • 癌症研究所

第 7 章 区域与国家分析

  • 全球罕见疾病诊断市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球罕见疾病诊断市场，依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 罕见疾病诊断市场竞争形势
  • 罕见疾病诊断市场的公司概况
    • Thermo Fisher Scientific Inc.
    • Roche Diagnostics
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Astellas Pharma Inc.

第31章 其他大型创新公司

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Sanofi Genzyme
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • BioMarin Pharmaceutical Inc.
  • OPKO Health Inc.
  • Sarepta Therapeutics Inc.
  • Natera Inc.
  • Invitae Corporation
  • Ultragenyx Pharmaceutical Inc.
  • Travere Therapeutics Inc.
  • BGI Genomics Co. Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14145

Rare disease diagnostics involves the identification and diagnosis of medical conditions that are considered rare or uncommon. These diagnostics play a crucial role in early detection and diagnosis, aiding in the selection of targeted and personalized treatment plans for uncommon disorders.

The primary tests included in rare disease diagnostics are genetic tests, general lab tests, and imaging tests. Genetic tests are laboratory procedures that examine chromosomes, genes, or gene expression in human cells or tissue. Various technologies, including capillary sequencing, whole genome sequencing, whole exome sequencing, and microarrays, utilize different samples such as DNA samples, buccal swab samples, blood, and saliva for the diagnosis of various diseases. These diseases include gastroenterology diseases, endocrine and metabolism disorders, hematology and oncology diseases, dermatology diseases, cardiovascular disorders, and neurology diseases. Rare disease diagnostics are employed by various end-users, including hospital laboratories, diagnostics laboratories, genetic testing laboratories, and cancer research laboratories.

The rare disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides rare disease diagnostics market statistics, including rare disease diagnostics industry global market size, regional shares, competitors with a rare disease diagnostics market share, detailed rare disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease diagnostics industry. This rare disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rare disease diagnostics market size has grown strongly in recent years. It will grow from $32.15 billion in 2023 to $35 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historical period can be attributed to the rise in demand for cloud-based diagnostics, an increased focus on improving efficiency, a higher prevalence of neurological diseases, an increase in immunological disorders, and heightened healthcare spending.

The rare disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $49.94 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of rare diseases, rising government initiatives, a growing number of hospitals and diagnostic laboratories, the expansion of hematology diseases, and an increase in healthcare infrastructure. Key trends expected in the forecast period include advancements in genetic testing technologies, the introduction of whole-genome sequencing and next-generation sequencing (NGS), extensive investments, and strategic collaborations for research initiatives.

The rare disease diagnostics market is poised for growth, driven by the increasing incidence of rare diseases. Rare diseases, characterized by their low prevalence in the population, necessitate specialized diagnostics for effective management, identification of potential therapeutics, and avoidance of unnecessary treatments. For instance, data from the International Osteoporosis Foundation (IOF) in February 2021 highlighted that over 300 million people worldwide suffer from rare diseases, affecting 3.5% to 5.9% of the global population. Additionally, Health Match reported in November 2022 that there are approximately 150 rare kidney ailments with a prevalence of 60-80 incidences per 100,000 people in America and Europe. Hence, the rising incidence of rare diseases is a driving force for the growth of the rare disease diagnostics market.

The growing aging population is another factor propelling the expansion of the rare disease diagnostics market. With an aging population, there is an increased need for early identification and personalized treatment approaches facilitated by rare disease diagnostics. According to The United States Census Bureau's June 2023 report, the median age in the United States rose to 38.9 years in 2022, indicating a continuous aging trend in the population. This demographic shift is contributing to the growth of the rare disease diagnostics market by improving the overall management of health conditions in the elderly.

Advancements in technology have become a prominent trend in the rare disease diagnostics market, with major companies adopting new technologies to sustain their market position. For example, in April 2023, Centogene GmbH introduced CentoGenome, a whole genome sequencing solution designed for diagnosing rare and neurodegenerative diseases. This advanced next-generation sequencing (NGS)-based assay covers a wide range of disease-causing variants, offering a comprehensive approach to rare disease diagnostics.

Major companies in the rare disease diagnostics market are also focusing on developing innovative products, such as genetic testing, to enhance their market share. Genetic testing for rare cancers involves using advanced genetic analysis techniques to identify and understand genetic components associated with these diseases. Illumina, a biotechnology company, launched the TruSight Oncology Comprehensive test kit in March 2022, which analyzes 517 cancer-related genes across nearly 30 solid tumor types in a single tissue sample.

In April 2022, Sema4 Holding Corp., a patient-centered health intelligence company, acquired GeneDx for $623 million. This strategic acquisition is expected to bolster Sema4's AI-driven genomic and clinical data analytics platform. GeneDx is a genomic testing service provider specializing in the diagnosis of rare and ultra-rare pediatric genetic illnesses.

Major companies operating in the rare disease diagnostics market report are Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Astellas Pharma Inc., Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BioMarin Pharmaceutical Inc., OPKO Health Inc., Sarepta Therapeutics Inc., Natera Inc., Invitae Corporation, Ultragenyx Pharmaceutical Inc., Travere Therapeutics Inc., BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., Agios Pharmaceuticals Inc., Orphazyme A/S, RareCyte Inc.

North America was the largest region in the rare disease diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the rare disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The rare disease diagnostics market consists of revenues earned by entities by providing services such as clinical evaluation, parallel sequencing, targeted sequencing, laboratory testing, and specialist consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease diagnostics market also includes sales of vision evaluation instruments, blood pressure cuffs, cardiac monitors, and advanced imaging equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Disease Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rare disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Test Type: Genetic Test; General Lab Test; Imaging Test
  • 2) By Technology: Capillary Sequencing; Whole Genome Sequencing; Whole Exome Sequencing; Microarrays
  • 3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample; Buccal Swab Sample; Blood; Saliva
  • 4) By Disease Type: Gastroenterology Disease; Endocrine And Metabolism Disorders Disease; Hematology And Oncology Disease; Dermatology Disease; Cardiovascular Disorders; Neurology Disease
  • 5) By End User: Hospital Laboratories; Diagnostics Laboratories; Genetic Testing Laboratories; Cancer Research Laboratories
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Astellas Pharma Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rare Disease Diagnostics Market Characteristics

3. Rare Disease Diagnostics Market Trends And Strategies

4. Rare Disease Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Rare Disease Diagnostics Market Size and Growth

  • 5.1. Global Rare Disease Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Rare Disease Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Rare Disease Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Rare Disease Diagnostics Market Segmentation

  • 6.1. Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetic Test
  • General Lab Test
  • Imaging Test
  • 6.2. Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Capillary Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Microarrays
  • 6.3. Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Deoxyribonucleic Acid (DNA) Sample
  • Buccal Swab Sample
  • Blood
  • Saliva
  • 6.4. Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gastroenterology Disease
  • Endocrine And Metabolism Disorders Disease
  • Hematology And Oncology Disease
  • Dermatology Disease
  • Cardiovascular Disorders
  • Neurology Disease
  • 6.5. Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Laboratories
  • Diagnostics Laboratories
  • Genetic Testing Laboratories
  • Cancer Research Laboratories

7. Rare Disease Diagnostics Market Regional And Country Analysis

  • 7.1. Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Rare Disease Diagnostics Market

  • 8.1. Asia-Pacific Rare Disease Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Rare Disease Diagnostics Market

  • 9.1. China Rare Disease Diagnostics Market Overview
  • 9.2. China Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Rare Disease Diagnostics Market

  • 10.1. India Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Rare Disease Diagnostics Market

  • 11.1. Japan Rare Disease Diagnostics Market Overview
  • 11.2. Japan Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Rare Disease Diagnostics Market

  • 12.1. Australia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Rare Disease Diagnostics Market

  • 13.1. Indonesia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Rare Disease Diagnostics Market

  • 14.1. South Korea Rare Disease Diagnostics Market Overview
  • 14.2. South Korea Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Rare Disease Diagnostics Market

  • 15.1. Western Europe Rare Disease Diagnostics Market Overview
  • 15.2. Western Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Rare Disease Diagnostics Market

  • 16.1. UK Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Rare Disease Diagnostics Market

  • 17.1. Germany Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Rare Disease Diagnostics Market

  • 18.1. France Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Rare Disease Diagnostics Market

  • 19.1. Italy Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Rare Disease Diagnostics Market

  • 20.1. Spain Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Rare Disease Diagnostics Market

  • 21.1. Eastern Europe Rare Disease Diagnostics Market Overview
  • 21.2. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Rare Disease Diagnostics Market

  • 22.1. Russia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Rare Disease Diagnostics Market

  • 23.1. North America Rare Disease Diagnostics Market Overview
  • 23.2. North America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Rare Disease Diagnostics Market

  • 24.1. USA Rare Disease Diagnostics Market Overview
  • 24.2. USA Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Rare Disease Diagnostics Market

  • 25.1. Canada Rare Disease Diagnostics Market Overview
  • 25.2. Canada Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Rare Disease Diagnostics Market

  • 26.1. South America Rare Disease Diagnostics Market Overview
  • 26.2. South America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Rare Disease Diagnostics Market

  • 27.1. Brazil Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Rare Disease Diagnostics Market

  • 28.1. Middle East Rare Disease Diagnostics Market Overview
  • 28.2. Middle East Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Rare Disease Diagnostics Market

  • 29.1. Africa Rare Disease Diagnostics Market Overview
  • 29.2. Africa Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Rare Disease Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Rare Disease Diagnostics Market Competitive Landscape
  • 30.2. Rare Disease Diagnostics Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Roche Diagnostics
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Quest Diagnostics Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Astellas Pharma Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Rare Disease Diagnostics Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Sanofi Genzyme
  • 31.5. Illumina Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Qiagen NV
  • 31.8. BioMarin Pharmaceutical Inc.
  • 31.9. OPKO Health Inc.
  • 31.10. Sarepta Therapeutics Inc.
  • 31.11. Natera Inc.
  • 31.12. Invitae Corporation
  • 31.13. Ultragenyx Pharmaceutical Inc.
  • 31.14. Travere Therapeutics Inc.
  • 31.15. BGI Genomics Co. Ltd.

32. Global Rare Disease Diagnostics Market Competitive Benchmarking

33. Global Rare Disease Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Rare Disease Diagnostics Market

35. Rare Disease Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Rare Disease Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Rare Disease Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Rare Disease Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer